Uganda's dependence on imported medicines has raised concerns among stakeholders, with over 80 percent of medicines sourced from abroad. This has resulted in much of the pharmaceutical value chain being kept outside the country. The issue was discussed at the Pharmaceutical Society of Uganda Annual CPD 2026, where stakeholders emphasized the need for stronger local research and manufacturing to retain more value in Uganda.
The Pharmaceutical Society of Uganda Annual CPD 2026 brought together various stakeholders in the pharmaceutical industry to discuss pressing issues affecting the sector. One of the key concerns raised was the country's heavy reliance on imported medicines, which has significant implications for the local economy and the healthcare system. Stakeholders argued that developing local research and manufacturing capabilities is crucial to reducing this dependence.
According to stakeholders, Uganda's reliance on imported medicines not only affects the country's economy but also limits access to essential medicines. The high cost of imported medicines and the challenges of procuring them have significant implications for the healthcare system, particularly in rural areas. Developing local manufacturing capabilities could help address these challenges and improve access to medicines.
The Pharmaceutical Society of Uganda has emphasized the need for a multi-stakeholder approach to address the issue of pharmaceutical import dependence. This includes collaboration between government agencies, private sector players, and research institutions to develop local research and manufacturing capabilities. The society has also called for increased investment in the pharmaceutical sector to support the development of local industries.
Reducing Uganda's dependence on imported medicines requires a comprehensive strategy that addresses the root causes of the problem. This includes investing in research and development, improving infrastructure, and enhancing regulatory frameworks. Stakeholders have also emphasized the need for government support and incentives to encourage local manufacturing and investment in the pharmaceutical sector.
The issue of pharmaceutical import dependence has significant implications for Uganda's healthcare system and economy. Developing local research and manufacturing capabilities could help address some of the challenges facing the healthcare system, including limited access to essential medicines. It could also help create jobs and stimulate economic growth.
The Pharmaceutical Society of Uganda Annual CPD 2026 provided a platform for stakeholders to discuss the issue of pharmaceutical import dependence and explore solutions. The event highlighted the need for a collaborative approach to address the challenges facing the pharmaceutical sector and to develop local research and manufacturing capabilities.
Key points
- Uganda's reliance on imported medicines is estimated to be over 80 percent.
- Stakeholders are calling for stronger local research and manufacturing to reduce Uganda's dependence on imported medicines.
- Developing local pharmaceutical industries could help improve access to essential medicines and stimulate economic growth.
